title: Thrombocytopoietic properties of oncostatin M.
abstract: Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
authors.forename: P M
authors.initials: PM
authors.lastname: Wallace
authors.forename: J F
authors.initials: JF
authors.lastname: MacMaster
authors.forename: J R
authors.initials: JR
authors.lastname: Rillema
authors.forename: J
authors.initials: J
authors.lastname: Peng
authors.forename: S A
authors.initials: SA
authors.lastname: Burstein
authors.forename: M
authors.initials: M
authors.lastname: Shoyab
mesh_terms: D000740:Anemia / Q000188:drug therapy; D000818:Animals; D001792:Blood Platelets / Q000166:cytology*; D004357:Drug Synergism; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D007377:Interleukin-3 / Q000008:administration & dosage; D015850:Interleukin-6 / Q000008:administration & dosage; D008533:Megakaryocytes / Q000166:cytology; D051379:Mice; D008809:Mice, Inbred C3H; D053683:Oncostatin M; D010455:Peptides / Q000008:administration & dosage*; D010976:Platelet Count / Q000187:drug effects; D013997:Time Factors
chemical_list: D007377:Interleukin-3; D015850:Interleukin-6; C508352:Osm protein, mouse; D010455:Peptides; D053683:Oncostatin M